CONTINUOUS GLUCOSE MONITORING IN DIABETES MANAGEMENT: CLINICAL BENEFITS AND THE ROLE OF FREESTYLE LIBRE
DOI:
https://doi.org/10.31435/ijitss.2(50).2026.5614Keywords:
Continuous Glucose Monitoring, FreeStyle Libre, Flash Glucose Monitoring, Time in Range (TIR), Hypoglycemia, Glycemic ControlAbstract
Diabetes poses a significant public health challenge and requires effective methods for monitoring and managing glucose levels. Traditional approaches, such as glycated hemoglobin (HbA1c) and self-monitoring of blood glucose (SMBG), have important limitations, including a limited ability to assess glycemic variability and detect hypoglycemic episodes. This study aims to present the development of continuous glucose monitoring (CGM) technologies, evaluate their impact on metabolic control and patients’ quality of life, and analyze the role of the FreeStyle Libre system in modern diabetes care. This literature review is based on an analysis of randomized controlled trials, observational studies, and clinical guidelines regarding CGM use. Real-world data and recent evidence on the development of diabetes technologies were also included. The findings indicate that CGM use is associated with improved glycemic control, including reduced HbA1c levels, increased time in range (TIR), and fewer hypoglycemic episodes. The FreeStyle Libre system, as an example of flash glucose monitoring technology, is particularly effective in reducing hypoglycemia, while real-world data suggest additional improvements in HbA1c levels. In summary, CGM represents a key component of modern diabetes care, enabling a more precise and personalized approach to treatment and supporting the digital transformation of healthcare.
References
World Health Organization. (2024). Diabetes. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/diabetes
Beck, R. W., Bergenstal, R. M., Cheng, P., Kollman, C., Carlson, A. L., Johnson, M. L., & Rodbard, D. (2019). The relationships between time in range, hyperglycemia metrics, and HbA1c. Journal of Diabetes Science and Technology, 13(4), 614–626. https://doi.org/10.1177/1932296818822496
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., Cobelli, C., Dassau, E., DeVries, J. H., Donaghue, K. C., Dovc, K., Doyle, F. J., Garg, S., Grunberger, G., Heller, S., ... Phillip, M. (2019). Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range. Diabetes Care, 42(8), 1593–1603. https://doi.org/10.2337/dci19-0028
Advani, A. (2020). Positioning time in range in diabetes management. Diabetologia, 63(2), 242–252. https://doi.org/10.1007/s00125-019-05027-0
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., Toschi, E., Wolpert, H., & Price, D. (2017). Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND randomized clinical trial. JAMA, 317(4), 371–378. https://doi.org/10.1001/jama.2016.19975
Maiorino, M. I., Signoriello, S., Maio, A., Chiodini, P., Bellastella, G., Scappaticcio, L., Longo, M., Caruso, P., Esposito, K., & Giugliano, D. (2020). Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: A systematic review with meta-analysis of randomized controlled trials. Diabetes Care, 43(5), 1146–1156. https://doi.org/10.2337/dc19-1459
American Diabetes Association Professional Practice Committee. (2025). Standards of care in diabetes—2025. Diabetes Care, 48(Suppl. 1), S1–S350. https://doi.org/10.2337/dc25-S001
Fokkert, M. J., van Dijk, P. R., Edens, M. A., Abbes, S., de Jong, D., Slingerland, R. J., & Bilo, H. J. G. (2017). Performance of the FreeStyle Libre flash glucose monitoring system in patients with type 1 and 2 diabetes mellitus. BMJ Open Diabetes Research & Care, 5(1), Article e000320. https://doi.org/10.1136/bmjdrc-2016-000320
Miller, E. M. (2020). Using continuous glucose monitoring in clinical practice. Clinical Diabetes, 38(5), 429–438. https://pmc.ncbi.nlm.nih.gov/articles/PMC7755046/
Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., ... Bergenstal, R. M. (2021). Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: A randomized clinical trial. JAMA, 325(22), 2262–2272. https://doi.org/10.1001/jama.2021.7444
Wu, X., Zhao, X., Chen, W., Chen, Q., Kong, L., & Li, P. (2025). A systematic review of continuous glucose monitoring sensors: Principles, core technologies and performance evaluation. Sensors and Actuators Reports, 10, Article 100361. https://doi.org/10.1016/j.snr.2025.100361
Morales-Dopico, L., & MacLeish, S. A. (2024). Expanding the horizon of continuous glucose monitoring into the future of pediatric medicine. Pediatric Research, 96(6), 1464–1474. https://doi.org/10.1038/s41390-024-03573-x
Alva, S., Brazg, R., Castorino, K., Kipnes, M., Liljenquist, D. R., & Liu, H. (2023). Accuracy of the third generation of a 14-day continuous glucose monitoring system. Diabetes Therapy, 14(4), 767–776. https://doi.org/10.1007/s13300-023-01385-6
Freckmann, G., Eichenlaub, M., Waldenmaier, D., Pleus, S., Link, M., Kamecke, U., Haug, C., Nichols, J. H., Hinzmann, R., & Heinemann, L. (2023). Clinical performance evaluation of continuous glucose monitoring systems: A scoping review and recommendations for reporting. Journal of Diabetes Science and Technology, 17(6), 1506–1526. https://doi.org/10.1177/19322968231190941
Didyuk, O., Econom, N., Guardia, A., Livingston, K., Klueh, U., & Grainger, D. W. (2020). Continuous glucose monitoring devices: Past, present, and future. Journal of Diabetes Science and Technology, 14(1), 1–13. https://doi.org/10.1177/1932296819899394
Bender, C., Vestergaard, P., & Cichosz, S. L. (2025). The history, evolution and future of continuous glucose monitoring (CGM). Diabetology, 6(3), Article 17. https://doi.org/10.3390/diabetology6030017
Janapala, R. N., Jayaraj, J. S., Fathima, N., Kashif, T., Usman, N., Dasari, A., Jahan, N., & Sachmechi, I. (2019). Continuous glucose monitoring versus self-monitoring of blood glucose in type 2 diabetes mellitus: A systematic review with meta-analysis. Cureus, 11(9), Article e5634. https://doi.org/10.7759/cureus.5634
Uhl, S., Choure, A., Rouse, B., Loblack, A., & Reaven, P. (2024). Effectiveness of continuous glucose monitoring on metrics of glycemic control in type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. The Journal of Clinical Endocrinology & Metabolism, 109(4), 1119–1131. https://doi.org/10.1210/clinem/dgad652
Ólafsdóttir, A. F., Polonsky, W. H., Bolinder, J., Hirsch, I. B., Dahlqvist, S., Wedel, H., Nyström, T., Wijkman, M., Schwarcz, E., Hellman, J., Heise, T., & Lind, M. (2018). A randomized clinical trial of the effect of continuous glucose monitoring on nocturnal hypoglycemia, daytime hypoglycemia, glycemic variability, and hypoglycemia confidence in persons with type 1 diabetes treated with multiple daily insulin injections (GOLD-3). Diabetes Technology & Therapeutics, 20(4), 274–284. https://doi.org/10.1089/dia.2017.0363
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., ... Ólafsdóttir, A. F. (2017). Continuous glucose monitoring vs. conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: The GOLD randomized clinical trial. JAMA, 317(4), 379–387. https://doi.org/10.1001/jama.2016.19976
Beck, R. W., Bergenstal, R. M., Riddlesworth, T. D., Kollman, C., Li, Z., Brown, A. S., & Close, K. L. (2019). Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care, 42(3), 400–405. https://doi.org/10.2337/dc18-1444
Lu, J., Ma, X., Zhou, J., Zhang, L., Mo, Y., Ying, L., Lu, W., Zhu, W., Bao, Y., Vigersky, R. A., & Jia, W. (2018). Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care, 41(11), 2370–2376. https://doi.org/10.2337/dc18-1131
Charleer, S., De Block, C., Van Huffel, L., Broos, B., Fieuws, S., Nobels, F., Mathieu, C., & Gillard, P. (2020). Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): A prospective observational real-world cohort study. Diabetes Care, 43(2), 389–397. https://doi.org/10.2337/dc19-1610
Clark, T. L., Polonsky, W. H., & Soriano, E. C. (2024). The potential impact of continuous glucose monitoring use on diabetes-related attitudes and behaviors in adults with type 2 diabetes: A qualitative investigation of the patient experience. Diabetes Technology & Therapeutics, 26(10), 700–708. https://doi.org/10.1089/dia.2023.0612
Yoo, J. H., Kim, G., Lee, H. J., Sim, K. H., Jin, S.-M., & Kim, J. H. (2022). Effect of structured individualized education on continuous glucose monitoring use in poorly controlled patients with type 1 diabetes: A randomized controlled trial. Diabetes Research and Clinical Practice, 184, Article 109209. https://doi.org/10.1016/j.diabres.2022.109209
Haak, T., Hanaire, H., Ajjan, R. A., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017). Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: A multicenter, open-label randomized controlled trial. Diabetes Therapy, 8(1), 55–73. https://doi.org/10.1007/s13300-016-0223-6
Jefferies, C. A., Boucsein, A., Styles, S. E., Chamberlain, B., Michaels, V. R., Crockett, H. R., De Lange, M., Lala, A., Cunningham, V., Wiltshire, E., Serlachius, A. S., & Wheeler, B. J. (2023). Effects of 12-week FreeStyle Libre 2.0 in children with type 1 diabetes and elevated HbA1c: A multicenter randomized controlled trial. Diabetes Technology & Therapeutics, 25(12), 827–835. https://doi.org/10.1089/dia.2023.0292
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016). Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: A multicentre, non-masked, randomised controlled trial. The Lancet, 388(10057), 2254–2263. https://doi.org/10.1016/S0140-6736(16)31535-5
Dunn, T. C., Xu, Y., Hayter, G., & Ajjan, R. A. (2018). Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: A European analysis of over 60 million glucose tests. Diabetes Research and Clinical Practice, 137, 37–46. https://doi.org/10.1016/j.diabres.2017.12.015
Evans, M., Welsh, Z., Ells, S., & Seibold, A. (2020). The impact of flash glucose monitoring on glycaemic control as measured by HbA1c: A meta-analysis of clinical trials and real-world observational studies. Diabetes Therapy, 11(1), 83–95. https://doi.org/10.1007/s13300-019-00720-0
Ajjan, R. A., Cummings, M. H., Jennings, P., Leelarathna, L., Rayman, G., & Wilmot, E. G. (2018). Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: Implications for clinical practice. Diabetes & Vascular Disease Research, 15(3), 175–184. https://doi.org/10.1177/1479164118756240
Carlson, A. L., Martens, T. W., Johnson, L., & Criego, A. B. (2021). Continuous glucose monitoring integration for remote diabetes management: Virtual diabetes care with case studies. Diabetes Technology & Therapeutics, 23(Suppl. 3), S56–S65. https://doi.org/10.1089/dia.2021.0241
Tchero, H., Kangambega, P., Briatte, C., Brunet-Houdard, S., Retali, G.-R., & Rusch, E. (2019). Clinical effectiveness of telemedicine in diabetes mellitus: A meta-analysis of 42 randomized controlled trials. Telemedicine and e-Health, 25(7), 569–583. https://doi.org/10.1089/tmj.2018.0128
Scott, S. N., Fontana, F. Y., Helleputte, S., Pickles, J., Laimer, M., Zueger, T., & Stettler, C. (2022). Use and perception of telemedicine in people with type 1 diabetes during the COVID-19 pandemic: A 1-year follow-up. Diabetes Technology & Therapeutics, 24(4), 276–280. https://doi.org/10.1089/dia.2021.0426
Alaslawi, H., Berrou, I., Al Hamid, A., Alhuwail, D., & Aslanpour, Z. (2022). Diabetes self-management apps: Systematic review of adoption determinants and future research agenda. JMIR Diabetes, 7(3), Article e28153. https://doi.org/10.2196/28153
Underwood, P., Hibben, J., Gibson, J., & DiNardo, M. (2022). Virtual visits and the use of continuous glucose monitoring for diabetes care in the era of COVID-19. Journal of the American Association of Nurse Practitioners, 34(3), 586–596. https://doi.org/10.1097/JXX.0000000000000659
Contreras, I., & Vehi, J. (2018). Artificial intelligence for diabetes management and decision support: Literature review. Journal of Medical Internet Research, 20(5), Article e10775. https://doi.org/10.2196/10775
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Magda Terbosh, Magdalena Dubaj , Justyna Ignarska, Alicja Judzińska, Sabina Kubicz Mzabi, Marlena Kwolek , Julia Osipowska, Bartosz Piech, Kamila Sobczyńska, Emilia Trojanowska
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
